Phase I trial of PulmoXen™ in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2014
Price : $35 *
At a glance
- Drugs Dornase alfa (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Pharmasyntez
- 09 Apr 2014 New trial record
- 07 Apr 2014 Safety data from a completed phase I trial were presented in a Xenetic Biosciences media release.
- 17 Jul 2013 Phase I trial was to be initiated in the third quarter of 2013, according to a Pharmsynthez media release.